• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Zydus Cadila receives tentative approval from US FDA for Cariprazine Capsule

expresspharmaDecember 13, 2021

Tag: Cariprazine , Zydus , Capsule

Zydus Pharmaceuticals Inc has received tentative approval from the United States Food and Drug Administration (FDA) to market Cariprazine Capsules in the strengths of 1.5 mg, 3 mg, 4.5 mg and 6 mg, the company notified via a statement.

It also said that Cariprazine is an atypical antipsychotic. Zydus’ Cariprazine Capsules are indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar disorder. The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.

Previous:Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

Next:Proximie Partners with Jhpiego in New Initiative to Improve Obstetric Surgical Care

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Zydus Cadila receives tentative approval from US FDA for Cariprazine Capsule | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Solid brand folic acid, vitamin K soft capsule

Solid brand folic acid, vitamin K soft capsule
Capsule Polisher

Capsule Polisher
NJP500/800/1200 Capsule Filling Machine

NJP500/800/1200 Capsule Filling Machine
Mycophenolate Mofetil capsules 250mg

Mycophenolate Mofetil capsules 250mg
Chloramphenicol　Capsules

Chloramphenicol　Capsules
Capsule Filter Integrity Tester V6.5

Capsule Filter Integrity Tester V6.5
Wholesale Price Sea Moss Capsules

Wholesale Price Sea Moss Capsules
Factory Supply Fisetin Capsule

Factory Supply Fisetin Capsule
Oxytetracycline capsule

Oxytetracycline capsule
45ml china pharma capsule tablet packaging container

45ml china pharma capsule tablet packaging container

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service